PIKA Recombinant SARS-CoV-2 Vaccine

· Yisheng Biopharma (Singapore) Pte. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PIKA Recombinant SARS-CoV-2 Vaccine, covering 2024-07-23 to 2024-07-23. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II/III Study of PIKA Recombinant SARS-CoV-2 Vaccine as a Booster Dose. [Phase 2, Phase 3]